Literature DB >> 115058

Mesenteric vascular effects of prostaglandins F2 alpha and B2. Possible advantages over vasopressin in control of gastrointestinal bleeding.

J W Fara, K H Barth, R I White, T E Bynum.   

Abstract

Mesenteric vascular effects of prostaglandins B2 and F2 alpha were studied and compared to those of vasopressin in the dog, cat and baboon. Vasopressin reduced superior mesenteric blood flow (SMBF) 80-100%, and significantly increased hepatic arterial blood flow and systemic arterial pressure. Prostaglandin B2 produced vasodilatation at low doses and biphasic vasodilatation/vasoconstriction at high doses. Prostaglandin F2 alpha elicited only vasoconstriction, reducing SMBF, left gastric, and inferior mesenteric blood flow 80-100%. Systemic arterial pressure was not significantly changed. Thus, vasopressin and prostaglandin F2 alpha are equally effective mesenteric vasoconstrictors. Because of reduced systemic effects, prostaglandin F2 alpha has excellent potential as a mesenteric vasoconstrictor to control gastrointestinal hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115058     DOI: 10.1148/133.2.317

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

Review 1.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

2.  Feeding mice a diet high in oxidized linoleic acid metabolites does not alter liver oxylipin concentrations.

Authors:  Nuanyi Liang; Marie Hennebelle; Susanne Gaul; Casey D Johnson; Zhichao Zhang; Irina A Kirpich; Craig J McClain; Ariel E Feldstein; Christopher E Ramsden; Ameer Y Taha
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-06-24       Impact factor: 3.015

3.  The response of neoplastic intestinal vessels to prostaglandin F2 alpha: angiographic observations with emphasis on therapeutic applications.

Authors:  S Kusano; K Murata; S Tominaga; T Matsubayashi; S Matama; T Takahashi
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.